ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 1155

$436K Total Retail Price of All Prescriptions

Rank: 79 out of 1155

452 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

22% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 7,467 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 514 409 S3 1 4
LEVOTHYROXINE SODIUM 496 434 2 2
LISINOPRIL 381 324 3 1
AMLODIPINE BESYLATE 338 307 4 6
SIMVASTATIN 312 281 5 3
LOSARTAN POTASSIUM 284 260 6 18
OMEPRAZOLE 270 189 7 5
ATENOLOL 205 181 8 10
METFORMIN HCL 204 187 9 7
PRAVASTATIN SODIUM 197 166 10 20
METFORMIN HCL ER 190 162 11 53
HYDROCHLOROTHIAZIDE 173 158 12 9
ZOLPIDEM TARTRATE 172 136 13 21
FUROSEMIDE 171 151 14 8
ATORVASTATIN CALCIUM 170 139 15 12
CITALOPRAM HBR 167 102 16 19
WARFARIN SODIUM 133 117 17 11
TAMSULOSIN HCL 119 118 18 27
POTASSIUM CHLORIDE 99 97 19 16
METOPROLOL TARTRATE 96 88 20 14
AZITHROMYCIN 90 76 21 57
PROAIR HFA 89 50 22 31
CLOPIDOGREL 82 71 23 70
ADVAIR DISKUS 81 53 24 35
GABAPENTIN 81 58 24 15
PREDNISONE 80 73 26 40
METOPROLOL SUCCINATE 73 55 27 17
ESTRADIOL 72 43 R 28 60
GLIMEPIRIDE 71 58 29 43
LOVASTATIN 70 70 30 13
FLUTICASONE PROPIONATE 65 60 31 37
LANTUS 63 43 32 39
LOSARTAN-HYDROCHLOROTHIAZIDE 60 31 33 65
GLYBURIDE 60 57 R 33 75
PLAVIX 57 52 35 115
ABILIFY 57 0 35 166
FLUOXETINE HCL 56 39 37 30
CRESTOR 56 41 37 34
ZETIA 56 49 37 129
ALLOPURINOL 54 50 40 29
CHOLESTYRAMINE 52 46 41 269
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.